Is Amygdalin Outcomes Weighing Detriments of Sorafenib Treatment In Female Mice With Kidney Injury Induced By Ehrlich Ascites Carcinoma Model? Preliminary study

The efficiency of amygdalin and doxorubicin combination on hepatocellular carcinoma and stromal myofibroblastic prostatic cells

Enhanced Cytotoxicity of Sorafenib in Hepatocellular Carcinoma through Synergistic Combination with Naringenin: A Molecular and Cellular Perspective

Effect of Sorafenib on Liver Biochemistry Prior to Vitamin B17 Coadministration in Ehrlich Ascites Carcinoma Mice Model: Preliminary Phase Study

The Anticancer Impact of Anthraquinones and Sorafenib on Rat Liver Cancer

CYTOTOXICITY OF SORAFENIB IN HUMAN HEPATOCELLULAR CARCINOMA CELLS

In vivo study using Amygdalin against mammalian tumors in a mice model

Antitumor Effect of Esculetin on Sorafenib -Treated Human Hepatocellular Carcinoma Cell Lines Via Suppression of VEGF-EGFR/RAS/ERK/NF-κB Pathway and Modulation of pI3K/ P38 Axis

Synergistic effect of avenanthramides and cisplatin co-treatment in Ehrlich ascites carcinoma-bearing mice

The Effect of Multidrug System on Treatment of Hepatocellular Carcinoma